Biblio

Export 1296 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2016
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
E. Aso, Andrés-Benito, P., and Ferrer, I., “Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.”, J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
E. Aso, Andrés-Benito, P., and Ferrer, I., “Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.”, J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
H. B. Mehta, Mehta, V., Tsai, C. - L., Chen, H., Aparasu, R. R., and Johnson, M. L., “Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”, J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
M. Takemoto, Sato, K., Hatanaka, N., Yamashita, T., Ohta, Y., Hishikawa, N., and Abe, K., “Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 1, pp. 205-11, 2016.
C. Peters, Bascuñán, D., Opazo, C., and Aguayo, L. G., “Differential Membrane Toxicity of Amyloid-β Fragments by Pore Forming Mechanisms.”, J Alzheimers Dis, vol. 51, no. 3, pp. 689-99, 2016.
L. Chang, Zhang, Y., Liu, J., Song, Y., Lv, A., Li, Y., Zhou, W., Yan, Z., Almeida, O. F. X., and Wu, Y., “Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons.”, J Alzheimers Dis, vol. 51, no. 1, pp. 197-212, 2016.
S. Wolfsgruber, Kleineidam, L., Wagner, M., Mösch, E., Bickel, H., Lϋhmann, D., Ernst, A., Wiese, B., Steinmann, S., König, H. - H., Brettschneider, C., Luck, T., Stein, J., Weyerer, S., Werle, J., Pentzek, M., Fuchs, A., Maier, W., Scherer, M., Riedel-Heller, S. G., and Jessen, F., “Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1135-1146, 2016.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., “Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo.”, J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
M. Lacalle-Aurioles, Navas-Sánchez, F. Javier, Alemán-Gómez, Y., Olazarán, J., Guzmán-De-Villoria, J. Adán, Cruz-Orduña, I., Mateos-Pérez, J. María, and Desco, M., “The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1051-64, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., “Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., “Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.
T. Qiu, Luo, X., Shen, Z., Huang, P., Xu, X., Zhou, J., and Zhang, M., “Disrupted Brain Network in Progressive Mild Cognitive Impairment Measured by Eigenvector Centrality Mapping is Linked to Cognition and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1483-1493, 2016.
Y. Zhai, Yamashita, T., Nakano, Y., Sun, Z., Morihara, R., Fukui, Y., Ohta, Y., Hishikawa, N., and Abe, K., “Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1311-9, 2016.
E. Gómez-Tortosa, Prieto-Jurczynska, C., Serrano, S., Franco-Macías, E., Olivié, L., Gallego, J., Guerrero-López, R., Trujillo-Tiebas, M. José, Ayuso, C., Ruiz, P. García, Pérez-Pérez, J., and Sainz, M. José, “Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion.”, J Alzheimers Dis, vol. 52, no. 1, pp. 25-31, 2016.
G. D. Femminella, Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J., and Edison, P., “Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?”, J Alzheimers Dis, vol. 51, no. 4, pp. 1275-89, 2016.
J. de Pedro-Cuesta, Martínez-Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. José Garc, Almazán-Isla, J., Ruiz-Tovar, M., Medrano, M. - J., Avellanal, F., Calero, O., and Calero, M., “Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
J. de Pedro-Cuesta, Martínez-Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. José Garc, Almazán-Isla, J., Ruiz-Tovar, M., Medrano, M. - J., Avellanal, F., Calero, O., and Calero, M., “Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
J. de Pedro-Cuesta, Martínez-Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. José Garc, Almazán-Isla, J., Ruiz-Tovar, M., Medrano, M. - J., Avellanal, F., Calero, O., and Calero, M., “Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
S. Gourmaud, Mouton-Liger, F., Abadie, C., Meurs, E. F., Paquet, C., and Hugon, J., “Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1659-1670, 2016.
L. Bonanni, Franciotti, R., Nobili, F., Kramberger, M. G., Taylor, J. - P., Garcia-Ptacek, S., N Falasca, W., Famá, F., Cromarty, R., Onofrj, M., and Aarsland, D., “EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1649-1657, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
S. Vandepitte, Van Den Noortgate, N., Putman, K., Verhaeghe, S., Faes, K., and Annemans, L., “Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials.”, J Alzheimers Dis, vol. 52, no. 3, pp. 929-65, 2016.
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., “Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.

Pages